Aesthetic Connect Public Company LimitedSET: TRP🇹🇭 TH

Board Performance · 2024

Compliance Monitoring — Overview

Monitoring of Compliance with Other CG Policies & Guidelines

The company places great importance on corporate governance and has established policies and practices related to corporate governance and business ethics. It also promotes genuine implementation to build trust among all stakeholders. In the past year, the company has monitored the compliance with good corporate governance practices, covering the following areas:

1. Employee care and non-discrimination

2. Anti-competitive practices

3. Environmental care, health, and safety in the organization.

4. Information security

The monitoring results show that the company has fully implemented the guidelines for each of these areas.

Prevention of Conflicts of Interest

Introduction

The Company has established a policy regarding the prevention of conflicts of interest based on the principle that any decision in conducting business activities must be made in the best interest of the Company and its shareholders only and should avoid actions that cause There is a conflict of interest by requiring the executive director And employees who are involved or have an interest in the items being considered must notify the company of their relationship or interest in the said item. and must not participate in the consideration and approval authority of such transactions. At the Board of Directors' meeting No. 1/2023 on February 23, 2023, a resolution was passed to approve the policy regarding the prevention of conflicts of interest.

Has the Company Acted to Prevent Conflicts of Interest?

Yes

Operations in the Past Year

In 2024, the company reviewed its Conflict of Interest Prevention Policy during the Board of Directors' Meeting No. 1/2024 on February 22, 2024. The policy was subsequently communicated to all directors, executives, and relevant stakeholders to ensure compliance with the following guidelines:

(1) Directors, executives, and employees should refrain from engaging in businesses of the same nature and in competition with the company’s business, whether such actions are taken for their own benefit or for the benefit of others, which may cause damage to the company, directly or indirectly. This includes becoming a partner, a shareholder with decision-making power, a director, or an executive in a business of the same nature and in significant competition with the company. Exceptions apply if the company has mechanisms in place to ensure that such actions will not negatively impact the company and will serve the best interests of the company and its shareholders. In any case, if a director, executive, or employee engages in a business of the same nature and in competition with the company, they must report it to the company immediately.

(2) Directors and executives should disclose any business transactions or activities in which they, their family members, relatives, or dependents are personally involved, which may lead to a conflict of interest with the company. This includes investments or interests in business partners or customers of the company, as well as holding any positions, including advisory roles, in business partners or customers of the company, regardless of whether such sales or services are conducted directly or indirectly with the company.

(3) Directors, executives, and employees of the company must make business operation decisions with the primary focus on the best interests of the company.

(4) Directors, executives, and employees of the company must avoid engaging in related-party transactions that may create conflicts of interest with the company. If such transactions are necessary, they must be conducted in the best interests of the company. Decisions and actions taken by directors, executives, and employees must be free from personal influence or influence from any related persons, whether by blood relation or otherwise. Such transactions must be carried out at fair and reasonable prices, comparable to dealings with external parties. If directors, executives, or employees need to approve or decide on transactions that may create conflicts of interest, they must report to their supervisor for approval. The individuals involved must not participate in the decision-making process.

(5) Directors, executives, and employees of the company must perform their duties with full dedication and effort, without engaging in any personal businesses that affect their responsibilities or working hours at the company.

(6) Directors, executives, and employees of the company must not engage in or participate in any business activities that compete with the company. They must not become partners, shareholders with decision-making power, directors, or executives in a competing business, whether they benefit directly or indirectly from such involvement.

(7) Directors, executives, and employees of the company must avoid financial involvement and/or relationships with external parties that may result in the company losing benefits or create conflicts of interest, thereby hindering the company’s operational efficiency.

(8) Directors, executives, and employees of the company must not disclose or use the company’s internal information for their own or others’ benefit, regardless of whether such actions cause harm to the company. Additionally, they must strictly comply with the company’s internal information usage policy.

(9) Directors, executives, and employees of the company must not engage in management or administrative actions that undermine the company’s interests or favor other individuals or legal entities, whether such actions are taken for their own benefit or for the benefit of others.

(10) Directors and executives must abstain from voting or participating in discussions and must not have any authority to approve transactions in which they have conflicts of interest. This also applies to transactions involving related parties or persons with vested interests that may result in conflicts of interest with the company. If directors or executives are involved in such transactions, they must disclose their relationships or interests in the transaction to the company.

Number of Conflict-of-Interest Cases

MetricCurrent YearPrevious YearTwo Years Ago
Total number of cases or issues related to conflicts of interest (cases)000

Prevention of the Use of Inside Information

Introduction

The Board of Directors' Meeting No. 1/2023 on February 23, 2023 resolved to approve the policy on the use of internal information in the company to supervise directors and executives in using internal information of the company which has not yet been disclosed to the public for personal gain. Provide knowledge to executive directors, including those holding management positions in accounting or finance who are department manager level or above or equivalent. Concerning the duty to prepare and submit a report on securities holdings to the Securities and Exchange Commission, including reporting the acquisition or sale of securities, as well as preparing and submitting a report on securities holdings, including suspending the trading of the company's securities. During the period before publishing financial statements or publishing information about the financial status and status of the company until the company has disclosed information to the public, when resigning, it is prohibited to reveal internal information or secrets of the company at all times. Until the secret information of the company's trading partners that they have learned from performing their duties has been disclosed to outsiders, even though the disclosure of such information will not cause any damage to the company and its trading partners, and the company will set strict limits. Disciplinary punishment if there is a violation of using inside information for personal gain.

Has the Company Acted to Prevent the Use of Inside Information?

Yes

Operations in the Past Year

In 2024, the policy on reporting securities holdings and the use of inside information was reviewed during the 1st/2024 Board of Directors meeting on February 22, 2024. The revised policy was communicated to all directors, executives, and relevant parties, who signed to acknowledge their responsibilities. These responsibilities include reporting their securities holdings in the company, as well as those of their spouses and minor children, and ensuring proper handling of inside information. The policy also outlines measures to govern directors and executives in handling non-public company information, as follows:

1. Education and Compliance

The company provides training for directors, executives, and senior managers in accounting or finance (department manager level or equivalent) on their duty to prepare and submit securities holding reports for themselves, their spouses, and their minor children. These reports must be submitted to the Securities and Exchange Commission (SEC) in compliance with Section 59 and the penalties under Section 275 of the Securities and Exchange Act B.E. 2535 (1992) (including subsequent amendments). Additionally, reports on securities acquisitions or disposals by these individuals must also be submitted under Section 246, with penalties as stated in Section 298 of the Act.

2. Reporting Requirements

Directors, executives, and senior managers in accounting or finance must submit their securities holding reports, including those of their spouses and minor children, to the company secretary before forwarding them to the SEC. These reports must be submitted: Within 30 days of being appointed as a director or executive. Within 3 business days of any securities transactions, including purchases, sales, transfers, or acquisitions.

3. Restrictions on Trading Before Public Disclosures

Directors, executives, senior managers in accounting or finance, and employees with access to material non-public information must refrain from trading company securities before financial reports or significant financial updates are disclosed to the public. The company will issue a formal written notice instructing these individuals to refrain from trading company securities for at least one month before public disclosure. After disclosure, they should wait at least 24 hours before engaging in securities transactions. Sharing material non-public information with others is strictly prohibited.

4. Confidentiality Obligation

Directors, executives, employees, and former employees are prohibited from disclosing the company’s confidential or insider information, including business partner information acquired during their tenure, to external parties. This applies even if such disclosure does not directly harm the company or its partners.

5. Disciplinary and Legal Consequences

Violations of the company’s policies on insider information misuse will result in disciplinary action, including written warnings, salary deductions, suspension without pay, or termination. Penalties will be determined based on intent and the severity of the violation. Individuals who misuse insider information for personal gain, including any related parties, may also face legal consequences under applicable laws.

Additionally, the company secretary has prepared a pre-announced stock trading blackout period schedule for directors and executives, aligning with the Board of Directors' meeting dates, as follows:

Board Meeting : Feb 22, 2024 Date Stock Trading Blackout Period :Jan 22, 2024 – Feb 23, 2024

Board Meeting : May 9, 2024 Date Stock Trading Blackout Period :Apr 9, 2024 – May 10, 2024

Board Meeting : Aug 8, 2024 Date Stock Trading Blackout Period :Jul 8, 2024 – Aug 9, 2024

Board Meeting : Nov 7, 2024 Date Stock Trading Blackout Period : Oct 7, 2024 – Nov 8, 2024

Number of Inside-Information Cases

MetricCurrent YearPrevious YearTwo Years Ago
Total number of cases or issues related to the use of inside information to seek benefits (cases)000

Anti-Corruption

Introduction

At the 1/2566 meeting of the company's board of directors on February 23, 2023, a resolution was passed to approve the anti-corruption policy and to review the policy at least once a year. In 2024, the policy was reviewed at the 1/2567 meeting of the company's board of directors on February 22, 2024. The company recognizes the importance of governance and business operations under the principles of good corporate governance. The company is committed to conducting business with integrity, honesty, and transparency. Therefore, the anti-corruption policy was established to ensure that directors, executives, and employees of the group avoid any actions that may involve corruption in any form, whether for personal or indirect benefit for themselves, their family, or closely related individuals. Additionally, the company has established an organizational structure with clearly defined roles, responsibilities, workflows, and lines of authority within each department to ensure checks and balances and to ensure appropriate internal control and monitoring.

Has the Company Acted on Anti-Corruption?

Yes

Operations in the Past Year

Anti-Corruption Operation Approach

Review of Appropriateness

The company has conducted a review of the appropriateness regarding anti-corruption efforts. On February 22, 2024, during the 1st/2024 Audit Committee meeting, the anti-corruption policy was reviewed and presented to the company's board of directors for consideration and approval.


Risk Assessment of Corruption

The risk management team has assessed and managed risks related to corruption that may arise from business operations and the company’s reputation. Measures and guidelines to prevent risks have been developed and presented to the Audit Committee. Additionally, the internal auditor has conducted an audit of the company’s internal control system for corruption in accordance with the audit plan. The internal auditor, being an independent external auditor, reports the audit results directly to the Audit Committee.


Guidelines for Conduct

The company has established strict guidelines for the board members, executives, and employees to follow, prohibiting any involvement in corruption in all forms, both direct and indirect, as follows:

1. Do not engage in any behavior that demonstrates an intention of corruption, including giving or receiving bribes from government officials, private sector employees, or stakeholders involved with the company, to secure or maintain business, competitive advantages, or personal benefits for themselves or others.

2. Do not ignore or neglect any actions that may involve corruption related to the company. It is the responsibility to report such actions to the supervisor or the responsible individual and cooperate in investigating the facts.

3. The company will ensure fairness and protection for individuals who refuse to participate in corruption or report corruption issues to the company, as specified in the whistleblower protection measures or for those who cooperate in reporting corruption.

4. Any individual engaging in corruption will violate the company's ethical standards and business conduct, and will face disciplinary actions according to the company's regulations. If the actions are illegal, legal penalties may also apply.

5. The company recognizes the importance of disseminating knowledge and ensuring understanding among those who perform duties related to the company or who may impact the company, to comply with the anti-corruption policy.

6. The company ensures that there is an appropriate and effective internal control system that is regularly reviewed to prevent corruption and improve work efficiency while minimizing risks. The internal control system includes both preventive and detective controls to reduce opportunities and incentives for misconduct and corruption. These include work role segregation, continuous monitoring, and prompt reporting by management regarding any irregularities or deficiencies, as well as improving preventive measures.

7. The company has an HR management process reflecting the company’s commitment to anti-corruption measures, from selection, training, performance evaluation, compensation, and promotion.

8. To ensure clarity in high-risk corruption areas, board members, executives, and employees at all levels must act with caution in the following matters:

8.1. Giving or receiving gifts and hosting events must be transparent, legal, in accordance with normal business practices, or customary traditions with appropriate value.

8.2. Donations or financial contributions must be transparent and legal, ensuring that such donations are not a cover for bribery.

8.3. Business operations, communications, negotiations, bidding, and other activities with government or private entities must be transparent and legal. Additionally, executives and employees must not give or accept bribes at any stage of operations.


The communication of these policies and guidelines has been shared with employees through the company’s communication channels and via the company website at https://teerapornclinic.com/corporate-governance/ to ensure that all executives and employees are informed and comply.

Form of Anti-Corruption Operations

Operation
Assessment and identification of corruption risk
Communication and training for employees on anti-corruption policy and guidelines
The monitoring of the evaluation of compliance with the anti- corruption policy
Review of the completeness and adequacy of the process by the Audit Committee or auditor
Review of appropriateness in anti-corruption

Number of Corruption Cases

MetricCurrent YearPrevious YearTwo Years Ago
Total number of cases or issues related to corruption (cases)000

Whistleblowing

Introduction

The company has implemented measures for whistleblowing and complaint reporting regarding legal violations, business ethics, and any behavior that may indicate fraud or corruption by directors, executives, or employees within the corporate group. Various communication channels have been established to provide employees and stakeholders with convenient and appropriate means to report misconduct or complaints to the company. Whistleblowers or complainants must provide details of their report, including their name, address, and contact number, and submit them through the designated reporting channels. 1. Whistleblowing and Corruption Complaint Reporting Channels Reports can be submitted to the Audit Committee via telephone or the Audit Committee Secretary’s email at whistleblower@teerapornclinic.com, or Through the website of Aesthetic Connect Public Company Limited at https://www.teerapornclinic.com Note: Once the Audit Committee Secretary registers complaints received via electronic or physical mail, the relevant department will be notified for further action as follows: If the complaint involves violations or non-compliance with personnel policies and procedures, it will be forwarded to the Human Resources Department. If the complaint involves violations or non-compliance with laws, government regulations, corporate governance policies, business ethics, or the company’s rules and regulations, it will be forwarded to the Audit Committee Secretary. If the complaint involves suspected fraudulent activities, including any actions aimed at obtaining unlawful benefits for oneself or others—such as embezzlement, corruption, or fraud—it will be forwarded to the Audit Committee. If the complaint under items 1–3 is complex or involves multiple departments, it will be escalated to the Chief Executive Officer (CEO).


2. Protection Measures and Confidentiality

To protect the rights of complainants and whistleblowers who act in good faith, the company will keep their names, addresses, and any identifiable information confidential. The information will be securely maintained and accessible only to those responsible for investigating the complaint. In cases involving allegations of corruption by executives, the Audit Committee will ensure the protection of whistleblowers, complainants, witnesses, and individuals providing information during the investigation process. They will be safeguarded from distress, harm, or unfair treatment resulting from their reporting, testifying, or providing information. Personnel responsible for handling complaints must strictly maintain the confidentiality of all complaints and related evidence. They are prohibited from disclosing any information to unauthorized individuals, except as required by law.


Has the Company Implemented Whistleblowing Procedures?

Yes

Operations in the Past Year

The company has established a whistleblowing channel on its website.

In 2024, no whistleblowers reported any issues to the company.

Number of Whistleblowing Cases

MetricCurrent YearPrevious YearTwo Years Ago
Total number of cases or issues received through whistleblowing channels (cases)000

Selection of Directors & Chief Executives

Selection — Introduction

The Nomination and Remuneration Committee was appointed at the Board of Directors Meeting No. 1/2566 of Aesthetic Connect Public Company Limited, held on February 23, 2023. The committee is responsible for recruiting, selecting, and proposing suitable candidates for the position of company director. According to the Board Charter, the Board of Directors must consist of at least five members, with no less than half (1/2) of the total board members residing in Thailand. Additionally, the board must include at least three independent directors or at least one-third of the total number of board members. Independent directors must meet all nine qualifications specified for independent directors. Furthermore, company directors must meet the following qualifications:

1. Must fully meet the qualifications of a director as stipulated by the Public Limited Companies Act, the Securities and Exchange Act, and the company’s regulations. Additionally, they must not possess any prohibited characteristics as defined by the Public Limited Companies Act and must not exhibit any traits that indicate a lack of suitability to be entrusted with managing a publicly held company, as specified by the Securities and Exchange Commission (SEC) regulations.

2. Must demonstrate leadership, a broad vision, and a strong understanding of the company’s business operations.

3. All board members must be able to perform their duties and express their opinions independently while dedicating sufficient time to fulfill their responsibilities.


Director Nomination

The Nomination and Remuneration Committee is responsible for establishing the criteria and policies for the nomination and remuneration of the Board of Directors and sub-committees. It is also tasked with identifying, selecting, and proposing suitable candidates for directorship positions and determining the remuneration for the Board of Directors. The details are as follows:

1. Establish criteria and policies for the nomination of the Board of Directors and sub-committees by considering the appropriateness of the number, structure, and composition of the board. Define the qualifications of directors to propose to the Board of Directors and/or seek approval from the shareholders' meeting as applicable.

2. Consider, nominate, select, and propose suitable candidates for the position of directors whose terms have ended and/or to fill vacant positions and/or for additional appointments.

3. Carry out other recruitment-related tasks as assigned by the Board of Directors.

4. Evaluate the performance of the company's top executive and present the assessment to the Board of Directors for consideration and approval.

Additionally, the company has granted shareholders the right to nominate individuals they deem qualified for election as company directors, with the nomination announcement posted on the company's website. However, no shareholders have proposed any candidates for election as company directors.

Directors & Chief Executives — Introduction

The Nomination and Remuneration Committee is responsible for considering and selecting directors, sub-committee members, and the Chief Executive Officer (CEO), ensuring they meet all the required qualifications as per the company's guidelines for board members, independent directors, and the CEO. In addition to meeting these qualifications, candidates must possess the necessary knowledge, skills, and work experience that align with the company’s business strategy. They must also be committed to dedicating sufficient time to effectively perform their duties as directors

1.1 Composition of the Board of Directors The Board of Directors shall consist of at least 5 members, with no less than half (1/2) of the total number of directors having their domicile in Thailand. The board must include at least 3 independent directors, or at least one-third of the total number of directors.

1.2 Shareholders shall be responsible for approving the appointment of the Board of Directors.

1.3 The Board of Directors shall select one member to serve as the Chairman of the Board.

1.4 The appointment of the Board of Directors shall comply with the company’s regulations and applicable legal requirements, ensuring transparency and clarity in the decision-making process, which must be based on the shareholders’ consideration.

Qualifications of Board Members

1. The board member must meet all qualifications as specified in the Public Limited Companies Act, the Securities and Exchange Act, and the company's regulations. Additionally, the individual must not have any disqualifications as defined by the law governing public limited companies, nor exhibit any characteristics that would make them unsuitable to be entrusted with managing a business that has public shareholders, as declared by the Securities and Exchange Commission.

2. The board member must possess leadership qualities, a broad vision, and an understanding of the company’s business operations.

3. All board members must be able to perform their duties and express their opinions independently. They must also be able to dedicate sufficient time to fulfill their responsibilities.

Selection of Executive Directors, Chief Executive Officer (CEO), and Senior Executives

At the first meeting of the Board of Directors in 2023, held on February 23, 2023, the Board approved the succession policy, which outlines the steps and processes for the succession of the Chief Executive Officer (CEO) and other senior executive positions. This is to ensure that the company has competent and capable executives to fill these key positions in the future.

1. Chief Executive Officer (CEO) Level

The selection and succession planning for the CEO position is managed by the Nomination and Remuneration Committee. This committee is responsible for creating a succession plan for the CEO, which is then submitted for review and approval by the Board of Directors. In the event that the CEO position becomes vacant, or the current CEO is unable to fulfill their duties, the Nomination and Remuneration Committee will follow the succession plan. The company will appoint an executive from a similar or senior level to act as the interim CEO until a qualified individual is selected and appointed, in accordance with the company's criteria. The candidate for the CEO position must possess vision, knowledge, competence, experience, and alignment with the company's culture. The Nomination and Remuneration Committee will evaluate potential candidates to ensure they meet these qualifications, have the necessary skills and experience for the company’s operations, and fully understand the business. The selected individual must be able to lead the company towards achieving its goals and objectives as outlined by the Board of Directors. After evaluation, the committee will propose the appointment of the selected candidate to the Board for final approval. This process aims to maintain investor and organizational confidence and ensure the continuity of the company's operations without disruption.

2. Vice President

The process of recruiting/selecting and planning the succession of executive positions is managed by the Nomination and Remuneration Committee, which prepares a succession plan for the position of Vice President for approval by the Board of Directors. For the recruitment and selection of a candidate to fill the Vice President position, the Nomination and Remuneration Committee will monitor the progress of the succession plan. In the event that the Vice President position becomes vacant or the incumbent is unable to perform their duties, the company will implement a system where an executive at a similar or Vice President level will temporarily assume the role until a suitable candidate is recruited and selected according to the company's criteria. The candidate must possess vision, knowledge, skills, experience, and be a good fit for the company's culture. For the recruitment of executives at the Vice President level, the Nomination and Remuneration Committee will initially review and screen candidates who meet the required qualifications. They must have the necessary knowledge, skills, and experience beneficial to the company's operations, as well as a deep understanding of the company’s business. They should be able to manage operations to achieve the objectives and goals set by the Board of Directors and will be presented to the Board for approval. This process ensures continued trust among investors, the organization, and employees, confirming that the company's operations will continue without disruption.

3. Executive level, starting from the Director level

When an executive position, starting from the Director level, becomes vacant or the incumbent is unable to perform their duties, the company will present the selected successor to the Executive Committee and/or the appointed committee responsible for recruitment/selection. The company’s succession planning process for executive positions is as follows:

3.1 Analyze the company’s business situation in terms of strategy, policies, investment plans, and expansion plans.

3.2 Evaluate the readiness of human resources to align with the company’s strategies, both short-term and long-term.

3.3 Develop a human resource readiness plan by either developing employees or recruiting new employees to replace those who leave.

3.4 Create recruitment and training plans in advance for employees who will retire or leave their positions prematurely.

3.5 Define the qualifications and competencies required for the position, which include knowledge, skills, personality traits, and attitudes. Additionally, create an Individual Development Plan (IDP) for each employee.

3.6 Select, assess performance, and evaluate the potential of employees to determine suitability for the position.

3.7 Utilize assessment tools to analyze the potential of employees.

3.8 Identify successors based on performance evaluation and potential analysis. Inform the employees in advance to prepare for the handover and learning process, and establish backup successors.

3.9 Develop and evaluate potential successors to determine if they can meet the expected development and performance targets. If the expectations are not met, the following actions will be taken:

3.9.1 Select and plan a new succession, or

3.9.2 Develop the backup successor (if available), or

3.9.3 Recruit and select from external candidates if the successor meets the qualifications required for a higher position with increased responsibilities. If there is a vacant position or a newly created higher position, propose promotions and acting appointments according to the company’s position structure policy. The promotion criteria will be reviewed and approved by the CEO and the Executive Chairman.


Selection Process — Introduction

The Nomination and Remuneration Committee is responsible for selecting and nominating qualified individuals for consideration by the Board of Directors and the shareholders' meeting for appointment, in accordance with the company's regulations.

Are Directors Selected Through the Nomination Committee?

Yes

Are Chief Executives Selected Through the Nomination Committee?

Yes

Number of Directors from Major Shareholders

0

Rights of Minority Shareholders on Director Appointment

The company grants shareholders the right to nominate individuals they deem qualified for consideration in the election of the company's directors. This opportunity is announced on the company's website, and the Corporate Secretary is responsible for compiling the nominations and submitting them to the Nomination and Remuneration Committee for review. The committee evaluates the qualifications of the nominated individuals before providing recommendations to the Board of Directors, which then decides whether to present the nominees to the shareholders' meeting for further consideration. However, no shareholders have submitted any nominations for director election.

Method of Director Appointment

Method
Method whereby each director requires approval votes more than half of the votes of attending shareholders with voting rights

Selection of Independent Directors

Criteria for Selecting Independent Directors

The Nomination and Remuneration Committee will jointly consider the qualifications of individuals to be appointed as independent directors, based on the qualifications and disqualifications of directors under the Public Limited Companies Act, the Securities and Exchange Act, the announcements by the Securities and Exchange Commission, the Capital Market Supervisory Board, the Stock Exchange of Thailand, as well as relevant regulations and/or rules. These will be presented to the Board of Directors for consideration. The Board will select independent directors from qualified individuals with relevant work experience and other appropriateness factors, in alignment with the company’s strategy and business operations. The selected candidates will then be presented to the shareholders’ meeting for approval of their appointment as directors of the company. According to the Board of Directors' Charter, the Board must consist of at least 5 directors, with no less than half (1/2) of the total number of directors having a domicile in Thailand. The Board must include no less than 3 independent directors, or at least one-third (1/3) of the total Board members. The independent directors must meet the following qualifications:

1.Does not hold more than 1% of the total voting shares of the company, the parent company, subsidiaries, affiliates, major shareholders, or controlling persons of the company. This includes shares held by related persons of the independent director.

2. Has never been or is not currently an executive director, employee, salaried consultant, or controlling person of the company, the parent company, subsidiaries, affiliates, major shareholders, or controlling persons of the company, unless at least 2 years have passed since holding such position.

3.Is not a person who is a relative by blood or law of any other director, executive, major shareholder, controlling person, or any individual proposed to be appointed as a director, executive, or controlling person of the company or its subsidiaries.

4.Has no business relationship or has never had a business relationship with the company, the parent company, subsidiaries, affiliates, major shareholders, or controlling persons of the company in a way that could interfere with the independent judgment. This includes not being or having been a significant shareholder or controlling person of a business with such relationships, unless at least 2 years have passed since the end of such a relationship.

5.Has never been an auditor of the company, the parent company, subsidiaries, affiliates, major shareholders, or controlling persons of the company, and is not a significant shareholder, controlling person, or partner in the audit firm where auditors of the company, the parent company, subsidiaries, affiliates, major shareholders, or controlling persons of the company are employed, unless at least 2 years have passed since the end of such a relationship.

6.Has never provided professional services, including legal or financial consulting services, for a fee exceeding 2 million Baht per year from the company, the parent company, subsidiaries, affiliates, major shareholders, or controlling persons of the company, and is not a significant shareholder, controlling person, or partner of the service provider, unless at least 2 years have passed since the end of such a relationship.

7.Has never been appointed as a director to represent the directors of the company, major shareholders, or shareholders related to major shareholders. 8.Does not operate a business that competes directly with the company or its subsidiaries, nor is a partner with a significant interest in a partnership or a director with management duties, employee, salaried consultant, or holds more than 1% of the voting shares in any other company that competes directly with the business of the company or its subsidiaries.

9.Has no other characteristics that would prevent them from giving an independent opinion regarding the operations of the company.

Business or Professional Relationships — Introduction

As of December 31, 2024, the company had three independent directors: Clinical Professor Dr. Apichati Sivayathorn, Mr. Somboon Wongrassamee, and Mr. Kirkchai Chaiyatham. Throughout the past year, all three independent directors had no business relationships with the company and did not provide any professional services to the company.

Did Any Independent Director Have a Business or Professional Relationship?

No

Director Development

Director Development — Introduction

The company has a policy to promote the development of knowledge, skills, and competencies for directors, executives, and employees, ensuring they are well-equipped for both current and future responsibilities. The company recognizes that its personnel are a vital asset and aims to support their growth and career advancement alongside the company. This is achieved through training programs and seminars, both internally and externally, in collaboration with specialized institutions, as deemed appropriate. All company directors have completed 100% of the training courses specifically designed for directors. The details of these courses are provided in Appendix 1.

Development of Directors in the Past Year

In 2021 - 2024, the director will attend various training courses that are beneficial to organizational management, such as

Qualifications for Director Selection — Introduction

Qualifications of Directors in the Nomination Process

1. Must not have any prohibited characteristics as specified by the Public Limited Companies Act, the Securities and Exchange Act, or any other relevant laws, including regulations issued by the Office of the Securities and Exchange Commission (SEC), the Capital Market Supervisory Board, the Stock Exchange of Thailand (SET), or any other applicable regulations and the company's Articles of Association.

2. Must possess work experience that benefits the company's operations, along with appropriate knowledge, skills, and experience in corporate management as outlined in the Board Skill Matrix. The individual must demonstrate honesty, integrity, and ethical conduct in business administration and utilize the director database as part of the new director recruitment process.

3. Independent directors must meet the qualifications set forth by the SEC and the SET. 4o

Evaluation of Board & Subcommittee Performance

Evaluation — Introduction

The Nomination and Remuneration Committee conducts an annual performance evaluation of the Board of Directors, subcommittees, and the Chief Executive Officer, at least once a year. The evaluation includes both a collective assessment of each committee and a self-assessment on an individual basis. The committee adopts and adapts self-assessment guidelines from the Stock Exchange of Thailand as a framework for monitoring performance, reviewing achievements, identifying challenges and obstacles encountered throughout the year, and incorporating feedback for improvement. This process aims to enhance the effectiveness of the Board of Directors and the Chief Executive Officer, ensuring that governance, oversight, and management practices align with good corporate governance principles.


Evaluation Criteria for the Performance of the Board of Directors and Subcommittees Board

1. Structure and Qualifications – Ensuring that the board's composition and qualifications are appropriate to enhance the efficiency of its operations.

2. Board Meetings – Evaluating the effectiveness of board meetings in enabling directors to perform their duties efficiently.

3. Roles, Duties, and Responsibilities – Assessing whether the board adequately prioritizes, reviews, and fulfills its responsibilities with sufficient time and attention.

4. Other Matters – Additional relevant considerations for the board’s performance evaluation.


Evaluation Criteria for the Performance of Individual Directors and Sub-Committee Members

1. Board Structure and Qualifications

2. Board Meetings

3.Roles, Duties, and Responsibilities of the Board

Evaluation Criteria — Introduction

Evaluation Process:

1.The Nomination and Compensation Committee establishes the evaluation form and criteria for scoring the evaluation.

2.The company secretary submits the evaluation forms, both by committee and individual, to all board members.

3.The board members complete the evaluation form. The company secretary collects and summarizes the evaluation results and reports them to the Nomination and Compensation Committee for submission to the board of directors for acknowledgment at the first meeting of the year. Any recommendations will be used to improve work efficiency for the maximum benefit of the business operations and corporate governance going forward.

Criteria for Evaluating Board Performance

Evaluation Criteria and Scoring Summary for Each Item (Out of a Total Score of 4.00):

- Score 3.90 - 4.00: Evaluation Criteria – Excellent

- Score 3.80 - 3.89: Evaluation Criteria – Very Good

- Score 3.50 - 3.79: Evaluation Criteria – Good

- Score 3.00 - 3.49: Evaluation Criteria – Fair

-Score Below 3.00: Evaluation Criteria – Needs Improvement

Evaluation of Board Performance in the Past Year


Board Performance Evaluation Summary for 2024

Board (by committee): Average score of 3.85, rated "Very Good."

Board (by individual): Average score of 3.89, rated "Very Good."


Sub-Committee Performance Evaluation Summary for 2024

Executive Committee (by committee): Average score of 3.86, rated "Very Good."

Executive Committee (by individual): Average score of 3.80, rated "Very Good."

Audit Committee (by committee): Average score of 3.98, rated "Excellent."

Audit Committee (by individual): Average score of 4.00, rated "Excellent."

Nomination and Compensation Committee (by committee): Average score of 4.00, rated "Excellent."

Nomination and Compensation Committee (by individual): Average score of 4.00, rated "Excellent."

Corporate Governance Committee (by committee): Average score of 4.00, rated "Excellent."


The CEO performance evaluation for 2024, held by Prof. Dr. Choladhis Sinrachtanant, had an average score of 3.84, rated "Very Good."



Evaluation Results

Evaluated BodyGroup — Carried Out?Group — Grade / Average ScoreGroup — Grade / Full ScoreIndividual (Self-Assessment) — Carried Out?Individual (Self-Assessment) — Grade / Average ScoreIndividual (Self-Assessment) — Grade / Full ScoreCross (Assessing Other Directors) — Carried Out?
Board Of DirectorYVery Good/3.85Excellent/4.00YVery Good/3.89Excellent/4.00N
Audit CommitteeYExcellent/3.98Excellent/4.00YExcellent/4.00Excellent/4.00N
Other SubcommitteeYExcellent/4.00Excellent/4.00YExcellent/4.00Excellent/4.00N
Executive CommitteeYVery Good/3.86Excellent/4.00YVery Good/3.80Excellent/4.00N
Other SubcommitteeYExcellent/4.00Excellent/4.00NN

Subcommittees

Subcommittees

Results of the Subcommittee's Duty PerformanceMeetings — Introduction

Nomination and Remuneration Committee's Key Activities in 2024 In 2024, the Nomination and Remuneration Committee performed its duties as outlined in its charter. The key activities can be summarized as follows:

1. Review the charter of the Nomination and Remuneration Committee to ensure that its operational guidelines align appropriately with the company’s business activities and remain relevant to the current circumstances.

2. Consider and approve the annual performance evaluation results of the Board of Directors and sub-committees, both as a group and individually, for submission to the Board of Directors for approval.

3. Review and nominate directors whose terms have expired for reappointment as company directors for another term. The selection process ensures that nominees meet all legal qualifications, have no disqualifying characteristics, uphold ethical standards, possess the necessary knowledge and expertise, demonstrate a strong track record, contribute to the organization’s success, and are committed to dedicating their time. The nominations will be submitted to the Board of Directors and subsequently to the 2024 Annual General Meeting of Shareholders for approval.

4. Review and evaluate the remuneration framework for the Board of Directors, subcommittees, and the Chief Executive Officer for the year 2024, in accordance with the company’s criteria and relevant considerations. The proposal will be submitted to the Board of Directors for approval before being presented to the Annual General Meeting of Shareholders for final approval.

The Nomination and Remuneration Committee has carried out its duties in accordance with the charter and additional assignments from the Board of Directors. The committee carefully considers the company’s performance and overall economic conditions, acting to the best of its ability to ensure benefits for shareholders and all relevant stakeholders.

(Mr. Somboon Wongrassamee )

Chairman of the Nomination and Remuneration Committee

Aesthetic Connect Public Company Limited

In 2024, the Risk Management Executive Committee performed its duties as outlined in the charter, with the key highlights summarized as follows:

1.Conducted a thorough assessment of risk factors affecting the company, both external and internal, and proposed principles and preventive measures to mitigate risks to an acceptable level. This ensured the achievement of corporate objectives and the creation of added value for the company.

2.Oversaw and monitored compliance with risk management policies, including reviewing and improving policies to enhance efficiency and effectiveness in risk control. 3.Supervised internal departments in analyzing potential risk factors, covering business risks, financial risks, operational risks, legal compliance risks, and emerging risks. Additionally, risk management plans were formulated to maintain risks at an acceptable level, including measures to address fraud and corruption risks.

4.Identified various risks, analyzed and assessed potential risks and trends that could impact the company, and developed preventive or risk-mitigation plans.

5.Reported on risk management operations, the company's risk status, changes, and necessary improvements to ensure alignment with established policies and strategies to the Audit Committee, which then presented the findings to the Board of Directors on a regular basis.


In summary, the Risk Management Executive Committee believes that in 2024, the company had an effective risk management system in place to oversee the key risks of the organization. The system was well-suited to the company’s business operations and activities, serving as a crucial factor in driving the organization’s growth and stable business expansion. It also ensured the maintenance of a strong financial position, enabling the company to generate a reasonable return for its shareholders.


(Mr. Chaiyot Denariyakul )

Chairman of the Risk Management Working Group

Aesthetic Connect Public Company Limited

The Risk Management Working Group had four members in 2025 and 2026. On November 8, 2027, two members resigned, namely:

1. Dr. Phonphong Chayangsu, who attended all 11 meetings out of 11 eligible meetings.

2. Cdr. Dr. Suwannee Jirayungyuen, R.N., who attended all 11 meetings out of 11 eligible meetings.

On the same day, the appointment of three new members was approved, increasing the total number of Risk Management Working Group members to five as of December 31, 2027, as listed in the table below.

Performing their assigned duties as detailed in the Charter in full, as summarized below:

1. Support, promote, and monitor the management team to ensure that business operations consider environmental sustainability, social responsibility, and good governance. These principles are integrated into the company’s annual strategy and work plans and incorporated into regular business processes to meet the expectations of various stakeholders.

2. Approve the company’s sustainability policies and goals under the ESG (Environmental, Social, and Governance) framework. For 2024, the committee approved a target to reduce municipal water and electricity consumption by 1%, using 2021 as the baseline year, and provided recommendations for appropriate implementation practices.

3. Approve the company's participation in the Corporate Governance Report of Thai Listed Companies (CGR) and the Annual General Meeting (AGM) Checklist quality assessment program.

4. Report on compliance with good corporate governance principles for 2024, covering the eight fundamental corporate governance principles.

5. Review the charter of the Corporate Governance Working Committee and the company’s corporate governance policy.

6. Set the schedule for the Corporate Governance Working Committee meetings for 2025 as follows:

- Meeting 1/2025: Thursday, February 13, 2025, from 5:00 PM to 6:00 PM

- Meeting 2/2025: Tuesday, July 29, 2025, from 5:00 PM to 6:00 PM

As a result of these efforts, the company received the following recognitions this year:

- Achieved an "Excellent" rating in the Corporate Governance Report of Thai Listed Companies (CGR) from the first year of its listing on the Stock Exchange of Thailand.

- Scored 92 points in the 2024 Annual General Meeting (AGM) Checklist assessment conducted by the Thai Investors Association from the first year of its listing on the Stock Exchange of Thailand.

The Corporate Governance Committee remains committed to upholding and supporting the company's operations responsibly in accordance with good corporate governance principles. It continues to create value for customers and all stakeholders, including communities, society, and the environment, ensuring the company earns sustainable trust and confidence.

( Mr. Somboon Wongrassamee )

Chairman of the Corporate Governance Working Group

Aesthetic Connect Public Company Limited

The report on the activities of the Corporate Social Responsibility (CSR) Working Group has been prepared and presented to the Board of Directors, highlighting the following key issues:

1.Review of the CSR Charter and Policies: The committee ensures the review of CSR-related charters and policies annually to align with ethical principles based on the standards of leading companies both domestically and internationally. This focuses on implementing good corporate governance to maintain a balance in operations across economic, community, social, and environmental areas, which contributes to sustainable business development.

2.Employee Training and Development: The committee supports training programs for both internal and external employees annually. This includes setting training schedules, budgets, and identifying participants. The aim is to develop employees’ work potential, safety, and personal knowledge. For example, first aid and CPR training is provided to enhance the ability to respond to emergencies.

3.Community and Social Activities: The committee continues to organize activities that focus on environmental impact reduction and avoid operations that may negatively affect the quality of life in surrounding communities. Some key activities include:

1) Supporting the Petchkasem Foundation in Bangkok by donating 100 burial cloths to the poor and unclaimed bodies.

2) Donating 20,000 baht to the Phra Mongkutklao Hospital Foundation to support medical care for soldiers, officials, and underprivileged patients.

3) Donating 20,000 baht to the Thai Rak Pa Foundation to promote conservation and restoration of critical watersheds in the country.

4) Donating 500,000 baht for the flooring of the Buddhist Hall at Wat Nirop Phimaram, Udon Thani.

5) Donating a whiteboard and water supplies for the monks and novices at Wat Moli Lokyarama Rajwarawihan.

6) Supporting the Sarnrak Village Children's Foundation with clothes, snacks, and medicine for children in Nakhon Pathom province.

4.Academic Knowledge Sharing: The committee also organizes academic knowledge-sharing activities both internally and externally. For example, Assoc. Prof. Dr. Choladhis Sinrachtanant delivered a special lecture on "Fat Grafting Rhinoplasty and Correcting Silcone Nose Issues" at the Pan Asian Academy of Facial Plastic and Reconstructive Surgery’s 12th Conference at the India International Centre in New Delhi, India. During this event, he exchanged knowledge, innovations, and experiences with leading experts in the field of facial plastic surgery from various countries. The committee continues to support academic, research, and innovation efforts to enhance the global recognition of Thai expertise in facial aesthetic surgery.


The Corporate Social Responsibility (CSR) Committee aims to ensure that all stakeholders benefit effectively, both economically and socially, while also supporting participation in activities that enhance the quality of life for society, communities, and the environment. This is done to ensure that CSR activities are conducted appropriately, transparently, and in a manner that builds confidence and trust among stakeholders.


(Mr. Chaiyot Denariyakul )

Chairman of the Social Responsibility Working Group

Aesthetic Connect Public Company Limited

On November 8, 2027, three committee members resigned, namely:

1. Prof. Dr. Choladhis Sinrachtanant, who attended 3 out of 3 eligible meetings.

2. Dr. Palapong Chayangsu, who attended 3 out of 3 eligible meetings.

3. Mr. Chakchalat Sinrachatanant, who attended 3 out of 3 eligible meetings.

On the same day, three new members were appointed to replace the resigning members.

As a result, as of December 31, 2027, the total number of committee members remained at five.

Meeting Attendance & Remuneration

Meeting Attendance — Sub-section Introduction

At the Board of Directors Meeting No. 6/2567, held on November 8, 2567, the Board resolved to approve the schedule for the Board of Directors meetings, Audit Committee meetings for the year 2568, as well as the Annual General Meeting of Shareholders in advance. Additionally, the Board determined the blackout period for securities trading as follows:

Board and Audit Committee Meeting Schedule for 2568

Meeting No. 1/2568 Audit Committee Meeting Date: Feb 20, 2025 Time: 16:00 - 17:30

Board of Directors Meeting Date: Feb 21, 2025Time: 17:30 - 19:00

Blackout Period for Securities Trading Date: Jan 21, 2025 - Feb 24, 2025

Meeting No. 2/2568 Audit Committee Meeting Date: May 8, 2025 Time: 16:00 - 17:30

Board of Directors Meeting Date: May 9, 2025 Time: 17:30 - 19:00

Blackout Period for Securities Trading Date: Apr 9, 2025 - May 13, 2025

Meeting No. 3/2568 Audit Committee Meeting Date: Aug 7, 2025 Time: 16:00 - 17:30

Board of Directors Meeting Date: Aug 8, 2025 Time: 17:30 - 19:00

Blackout Period for Securities Trading Date: Jul 8, 2025 - Aug 11, 2025

Meeting No. 4/2568 Audit Committee Meeting Date: Nov 6, 2025 Time: 16:00 - 17:30

Board of Directors Meeting Date: Nov 7, 2025 Time: 17:30 - 19:00

Blackout Period for Securities Trading Date: Oct 7, 2025 - Nov 10, 2025

AGM. Date: Apr 28, 2025 Time: 14:00


Justification for Directors' Non-Attendance

The three directors who were unable to attend the Board of Directors meeting requested leave due to other commitments.

Types of Remuneration of the Board of Directors

The Nomination and Compensation Committee is responsible for setting policies regarding both monetary and non-monetary compensation. The process of determining the compensation and other benefits for the board of directors and its sub-committees must be transparent and appropriate to their duties and responsibilities, in line with industry standards. Monetary Compensation: The Annual General Meeting of Shareholders for the year 2024, held on April 25, 2024, approved the determination of the compensation for the board of directors and its sub-committees for the year 2024. The compensation is set in the form of meeting fees, as previously approved for the board of directors and sub-committees for 2024, with a comparison to 2023 shown as follows:

Remuneration or Benefits Payable to the Board

MetricAmount (Baht)
Remunerations or benefits pending payment to the board of directors over the past year (baht)0

Supervision of Subsidiaries & Associated Companies

Supervision of Subsidiaries — Introduction

The company has an investment policy. This includes supervision of subsidiaries and associates. It will invest in businesses that are closely related or that bring benefits and support the company's business operations and take into account the returns of all stakeholders in order to strengthen stability and operating results.

Oversight Mechanism — Introduction

In supervising the operations of subsidiaries and associated companies, the Board of Directors will consider sending representatives of the Company who have qualifications and experience appropriate to the business in which the Company invests to be directors in subsidiaries and associated companies. of the said company This is so that the company can supervise the business and operations of its subsidiaries and associated companies as if they were a unit of the company. The company places great importance on having a good and transparent management system. Can be verified and will help maintain the benefits of the company's investments. The Company therefore requires the Company's representatives to manage the business of the subsidiaries and associated companies in the best interests of the Company and to ensure compliance with the laws related to the business operations of the subsidiaries and associated companies. In addition, sending representatives to act as directors in such subsidiaries and associated companies shall be in accordance with the Company's shareholding percentage in such subsidiaries and associated companies.

Does the Company Have Subsidiaries or Associated Companies?

No

Is There a Mechanism for Overseeing Subsidiaries and Associated Companies?

Yes

Mechanism for Overseeing Management of Subsidiaries

As of December 31, 2024, the company has not yet established any subsidiaries or joint ventures. According to the company's policy, if investments are made in subsidiaries or joint ventures, company representatives must be appointed as directors in proportion to the investment share. Additionally, the company must oversee internal control systems, financial accounting systems, and ensure the closure of accounts on a quarterly basis to facilitate the preparation of consolidated financial statements.

Oversight Mechanisms

Mechanism
Sending representatives to act as directors, executives or controlling persons in proportion to shareholdings
Defining the scope of powers, duties and responsibilities of directors and executives who represent the company in setting important policies
Disclosure of financial information and operating results
Transactions between the Company and related persons
Internal control system of the subsidiary operating the core business is appropriate and sufficient in the subsidiary operating the core business
Other important transactions

Board Duty Performance — Overview

Board Duty Performance — Overall Description

The Board of Directors, as representatives of the shareholders, is responsible for overseeing the company's business operations in compliance with the law, objectives, articles of association, and resolutions of the shareholders' meetings. This includes adhering to the principles of good corporate governance as prescribed by the Stock Exchange of Thailand ("SET") and the 2017 Corporate Governance Code for Listed Companies issued by the Securities and Exchange Commission ("SEC") to ensure sustainable value creation for the company. Additionally, the Board of Directors oversees the establishment of the company's vision, mission, goals, operational direction, strategic plans, budget, and policies. It also monitors the company’s performance and financial status on a quarterly basis to ensure the company's adaptability to various changing factors that may impact the business. This enables the company to operate smoothly and enhance its competitive advantage in the future.

Furthermore, the Board ensures the adequacy of the company’s internal control system and risk management while ensuring the accurate and complete disclosure of financial reports in accordance with relevant financial reporting standards. This serves to build confidence among investors and shareholders.

Audit Committee Duty Performance

Results of the Audit Committee's Duty Performance in the Past Year

Summary of the Key Responsibilities of the Audit Committee and Their Opinions and Reports to the Board of Directors during the Year

1. Review of Financial Reports: The Audit Committee reviewed the quarterly and annual financial reports, which were audited and confirmed by the external auditor to comply with generally accepted accounting standards. The financial reports were presented with accurate and complete disclosures. The Committee invited the external auditor and management responsible for preparing the financial reports to attend each meeting where financial statements were reviewed before being presented to the Board of Directors for approval. The Audit Committee believes that the financial reports were prepared in accordance with generally accepted accounting standards and adequately disclosed in the financial statement notes. Furthermore, the Committee held a meeting with the external auditor without management present to allow independent discussions.

2. Evaluation and Review of Internal Control Systems: The Audit Committee reviewed the internal control system based on reports from the external auditor, the internal audit team (Proud Advisory Co., Ltd.), and the risk management team. They assessed the sufficiency of the internal control system in accordance with guidelines set by the Securities and Exchange Commission (SEC). The Committee consistently reported its findings and opinions to the Board of Directors and management, ensuring that the internal controls were adequate to support effective and efficient operations, prevent or reduce risks and damages, and ensure reliable financial reporting. The quality of the internal control system has been continuously improved.

3. Oversight of Internal Audit Activities: The Audit Committee approved the appointment of Proud Advisory Co., Ltd., led by Mr. Parit Buapuen, as the external internal auditor based on their qualifications, including the sufficient number of staff, experience, knowledge, ability, and independence to perform the audit. The internal audit team evaluated the sufficiency of the internal control system based on established guidelines.

4. Compliance with Ethics, Laws, and Policies: The Audit Committee reviewed the corporate governance process, including the handling of complaints related to service quality, ethics, and fraud prevention. The Committee also monitored changes in securities and stock market laws and relevant regulations to ensure that the company operates in compliance with ethics, laws, and regulations. It is ensured that the company is continuously prepared for changes.

5. Review of Risk Management: The Audit Committee reviewed and provided opinions on the company’s organizational risks, risk management plans, and regular risk analysis reports from the risk management team. The Committee also supported the analysis of sustainability-related risks in ESG (Environmental, Social, and Governance) areas and reported the findings to the Board of Directors.

6. Review of Related Party Transactions and Potential Conflicts of Interest: The Audit Committee reviewed and provided opinions on the necessity and reasonableness of related party transactions and potential conflicts of interest, including contracts, agreements, and key terms, ensuring full and sufficient disclosure as required by the Stock Exchange of Thailand.

7. Selection and Appointment of Auditors: The Audit Committee evaluated the performance, knowledge, and understanding of the business by the auditors, the quality of their work, and the appropriateness of their fees. The Committee recommended the appointment of Office of Pitisevi Co., Ltd. as the external auditor for the year and proposed the annual audit fee to the Board of Directors for shareholder approval.

8. Evaluation of Performance and Review of the Charter: The Audit Committee conducted self-assessments both at the committee and individual levels and reviewed the Audit Committee Charter. This included evaluating the scope of duties and responsibilities in alignment with the Securities and Exchange Commission's guidelines. The results were submitted to the Board of Directors for approval.

9. Schedule of the Audit Committee Meetings for the Year 2025

Meeting 1/2025: Thursday, February 20, 2025, from 16:00 to 17:30

Meeting 2/2025: Thursday, May 8, 2025, from 16:00 to 17:30

Meeting 3/2025: Thursday, August 7, 2025, from 16:00 to 17:30

Meeting 4/2025: Thursday, November 6, 2025, from 16:00 to 17:30

The Audit Committee has performed its duties and responsibilities in accordance with the Audit Committee Charter and as delegated by the Board of Directors with care and to the best of its ability. The Audit Committee is of the opinion that the company’s financial reports and disclosures are sufficient, appropriate, reliable, and in compliance with generally accepted accounting standards. The company has an effective and adequate internal control system and risk management practices that are suitable for the business operations. Additionally, related party transactions and information are disclosed adequately, and the company complies with good corporate governance principles. There has also been continuous development and improvement in the quality of the internal control system.


(Mr. Somboon Wongrassamee )

Chairman of the Audit Committee

Aesthetic Connect Public Company Limited

Executive Committee Duty Performance

Results of the Executive Committee's Duty Performance in the Past Year

Summary of the Executive Committee’s Performance in 2024

In 2024, the Executive Committee performed its duties as stipulated in its charter. The key aspects of its performance are summarized as follows:


1.Strategic Planning and Budgeting: The committee reviewed and formulated business policies, strategic plans, and the annual budget for submission to the Board of Directors for approval. Additionally, it monitored the company’s operational performance on a monthly basis and provided guidance and recommendations to enhance long-term competitiveness.

2.Business Performance Monitoring: The committee reviewed, examined, and monitored the company's business operations to ensure that performance targets were met and presented relevant reports to the Board of Directors.

3.Budget Allocation and Project Feasibility: The committee evaluated the allocation of the annual budget and assessed the feasibility of new projects. It also oversaw project implementations by carefully analyzing opportunities, risks, strengths, and weaknesses to maximize business potential and ensure sustainable returns.

4.Approval of Financial Transactions: The committee approved financial expenditures for the company’s normal business transactions, ensuring that spending remained within the budget approved by the Board of Directors.

5.Corporate Governance and Ethical Compliance: The committee oversaw corporate management to ensure compliance with legal requirements, ethical standards, and corporate governance principles. This aimed to prevent and mitigate potential conflicts of interest within the organization.

6.Dividend Distribution Approval: The committee reviewed the company’s financial performance and proposed interim or annual dividend payments for approval by the Board of Directors.

7.Organizational Structure and Executive Appointments: The committee determined the company’s organizational structure, management authority, and key personnel decisions. This included appointments, hiring, transfers, dismissals, and the determination of salaries, compensation, and bonuses for executives from the Chief Officer level and above, except for the Chief Executive Officer.

8.Review of the Executive Committee Charter: The committee periodically reviewed its charter to ensure that its duties and responsibilities remained appropriate and aligned with current circumstances and evolving business environments.


The Executive Committee has performed its duties within the scope of its authority and responsibilities as defined in its charter with due diligence, prudence, transparency, integrity, and reasonableness. It has prioritized the best interests of shareholders and all stakeholders while ensuring that the company operates efficiently, complies with legal and corporate governance principles, and fosters sustainable and stable business growth.


( Prof. Dr. Choladhis Sinrachtanant )

Chief Executive Officer

Aesthetic Connect Public Company Limited

Contents